Patent details

EP1353952 Title: FLT4(VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY

Basic Information

Publication number:
EP1353952
PCT Application Number:
PCT/US/2002/001784
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027173616
PCT Publication Number:
WO/2002/060950
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FLT4(VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
French Title of Invention:
FLT4 (VEGFR-3) UTILISE COMME CIBLE POUR L'IMAGERIE DES TUMEURS ET LE TRAITEMENT ANTITUMORAL
German Title of Invention:
FLT4 (VEGFR-3) ALS EIN ZIEL FÜR KREBS DARSTELLUNG UND ANTI-KREBS-BEHANDLUNG
SPC Number:

Dates

Filing date:
22/01/2002
Grant date:
11/04/2007
EP Publication Date:
11/04/2007
PCT Publication Date:
08/08/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/10/2003
EP B1 Publication Date:
11/04/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/01/2008
Expiration date:
22/01/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/01/2002
 
 

Name:
LUDWIG INSTITUTE FOR CANCER RESEARCH
Address:
605 Third Avenue, New York, New York 10158, United States (US)

Name:
Licentia Ltd.
Address:
Erottajankatu 19 B 6th floor, 00130 Helsinki, Finland (FI)

Inventor

1

Name:
ALITALO Kari
Address:
Finland (FI)

2

Name:
MAKINEN Taija, Dept. of Mol. Neurobiology
Address:
Germany (DE)

Priority

Priority Number:
765534
Priority Date:
19/01/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/71;
Filing date Document type Number of pages